Cargando…

Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A

PURPOSE: To evaluate the incidence of transient dry eye associated with LASIK for myopia and the efficacy of topical cyclosporine A administration. METHODS: Group A was formed from 145 (82 female, 63 male) eyes that developed clinically significant dry eye within 1 month post-LASIK and were subjecte...

Descripción completa

Detalles Bibliográficos
Autor principal: Kanellopoulos, Anastasios John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438263/
https://www.ncbi.nlm.nih.gov/pubmed/30988596
http://dx.doi.org/10.2147/OPTH.S188521
_version_ 1783407075318038528
author Kanellopoulos, Anastasios John
author_facet Kanellopoulos, Anastasios John
author_sort Kanellopoulos, Anastasios John
collection PubMed
description PURPOSE: To evaluate the incidence of transient dry eye associated with LASIK for myopia and the efficacy of topical cyclosporine A administration. METHODS: Group A was formed from 145 (82 female, 63 male) eyes that developed clinically significant dry eye within 1 month post-LASIK and were subjected to cyclosporine A treatment. A “non-symptomatic for dry eye” and age- and gender-matched group (group B) was formed from the same pool of patients to serve as control. Schirmer’s, tear film break-up time (TBUT) and Ocular Surface Disease Index (OSDI) questionnaire were evaluated. Central corneal epithelial thickness (CET) and topographic epithelial thickness variability (TVT) were evaluated as quantitative dry eye objective markers. Subjective patient survey was also assessed. RESULTS: Mean age was 39.7±6.2 years for the female and 47.67±9.5 years for the male patients, in group A. Schirmer’s test mean preoperative value was 8.4±3.1 mm; and 4.5±3.6 mm at 1 month post-LASIK. Statistically significant decrease from 1 month post-LASIK baseline was found at 12 months (8.2±2.1 mm; P=0.02). Mean preoperative TBUT value was 7.5±2.5 seconds, 6.5±3.1 seconds at 1 month postoperatively, and 7.6±2.0 seconds at 12 months postoperatively, statistically significant to baseline (P=0.04). Preoperatively, CET was 52.37±3.40 µm and TTV was 1.24±0.57 µm, 59.87±3.89 µm, and 2.74±0.57 µm at 1 month post-LASIK respectively and at 12 months, 55.42±2.75 µm and 1.39±0.96 µm. The differences in CET between 12 months post-LASIK vs baseline were statistically significant (P=0.007). The mean preoperative OSDI scores were 11.47±9.97 for group A and 11.79±10.31 for group B (P=0.782), which changed to 23.03±10.17 and 15.13±9.49 at 12 months postoperatively (P<0.05), respectively. Following commencement of cyclosporine A treatment in group A, statistically significant improvement was noted, greater than the one in group B, in all metrics at the 12-month examination in comparison to the 1-month baseline. CONCLUSION: Topical cyclosporine A treatment is an effective alternative in the management of LASIK for myopia-related transient dry eye. Optical coherence tomography epithelial mapping may provide an objective benchmark in diagnosing and monitoring this significant disorder and its correlation with visual symptoms.
format Online
Article
Text
id pubmed-6438263
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64382632019-04-15 Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A Kanellopoulos, Anastasios John Clin Ophthalmol Original Research PURPOSE: To evaluate the incidence of transient dry eye associated with LASIK for myopia and the efficacy of topical cyclosporine A administration. METHODS: Group A was formed from 145 (82 female, 63 male) eyes that developed clinically significant dry eye within 1 month post-LASIK and were subjected to cyclosporine A treatment. A “non-symptomatic for dry eye” and age- and gender-matched group (group B) was formed from the same pool of patients to serve as control. Schirmer’s, tear film break-up time (TBUT) and Ocular Surface Disease Index (OSDI) questionnaire were evaluated. Central corneal epithelial thickness (CET) and topographic epithelial thickness variability (TVT) were evaluated as quantitative dry eye objective markers. Subjective patient survey was also assessed. RESULTS: Mean age was 39.7±6.2 years for the female and 47.67±9.5 years for the male patients, in group A. Schirmer’s test mean preoperative value was 8.4±3.1 mm; and 4.5±3.6 mm at 1 month post-LASIK. Statistically significant decrease from 1 month post-LASIK baseline was found at 12 months (8.2±2.1 mm; P=0.02). Mean preoperative TBUT value was 7.5±2.5 seconds, 6.5±3.1 seconds at 1 month postoperatively, and 7.6±2.0 seconds at 12 months postoperatively, statistically significant to baseline (P=0.04). Preoperatively, CET was 52.37±3.40 µm and TTV was 1.24±0.57 µm, 59.87±3.89 µm, and 2.74±0.57 µm at 1 month post-LASIK respectively and at 12 months, 55.42±2.75 µm and 1.39±0.96 µm. The differences in CET between 12 months post-LASIK vs baseline were statistically significant (P=0.007). The mean preoperative OSDI scores were 11.47±9.97 for group A and 11.79±10.31 for group B (P=0.782), which changed to 23.03±10.17 and 15.13±9.49 at 12 months postoperatively (P<0.05), respectively. Following commencement of cyclosporine A treatment in group A, statistically significant improvement was noted, greater than the one in group B, in all metrics at the 12-month examination in comparison to the 1-month baseline. CONCLUSION: Topical cyclosporine A treatment is an effective alternative in the management of LASIK for myopia-related transient dry eye. Optical coherence tomography epithelial mapping may provide an objective benchmark in diagnosing and monitoring this significant disorder and its correlation with visual symptoms. Dove Medical Press 2019-03-25 /pmc/articles/PMC6438263/ /pubmed/30988596 http://dx.doi.org/10.2147/OPTH.S188521 Text en © 2019 Kanellopoulos. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Kanellopoulos, Anastasios John
Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A
title Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A
title_full Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A
title_fullStr Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A
title_full_unstemmed Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A
title_short Incidence and management of symptomatic dry eye related to LASIK for myopia, with topical cyclosporine A
title_sort incidence and management of symptomatic dry eye related to lasik for myopia, with topical cyclosporine a
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438263/
https://www.ncbi.nlm.nih.gov/pubmed/30988596
http://dx.doi.org/10.2147/OPTH.S188521
work_keys_str_mv AT kanellopoulosanastasiosjohn incidenceandmanagementofsymptomaticdryeyerelatedtolasikformyopiawithtopicalcyclosporinea